Skip to content
EmergingResearch compoundReference only

J‑147

Curcumin-based experimental compound that improved memory in mice; effect in humans not proven.

NootropicLongevityMitochondrialNeuroprotectionMemoryBDNFAnti-fatigue

Pharmacology

ClassMitochondrial · Neuroprotection · Memory
Primary targetBDNF / NGF induction
Targets3 receptor targets
EvidenceReference only
Affected systemsBDNFAnti-fatigue

Contents

DETAILED OVERVIEW

What is J-147?

J-147 is an experimental compound developed by researchers at the Salk Institute, starting from curcumin, the yellow pigment of turmeric. It has not been approved as a medicine: it has no medical authorization in the EU, and the US FDA has not approved it. It is sold as a research chemical, and the purity and composition of such products are unchecked.

Research suggests it acts on the cells' energy-producing parts (the mitochondria) and increases the production of substances that help nerve cells grow and survive. In mouse models of Alzheimer's disease it reduced abnormal protein deposits and improved memory. A human study has also been started, but there is no long-term human safety data and its side effects are unknown. In theory it may keep platelets from clumping together, which matters during blood-thinning treatment, and its drug interactions are not known. It must not be used in pregnancy or breastfeeding, because no reproductive safety data exist.

Mechanism

ATP5A modulation + BDNF/NGF inducer

Half-life

3-5 h (animal pharmacokinetics)

Legal status

Investigational, not FDA-approved

Receptor profile

  • BDNF / NGFStrong
  • Mitochondrial ATP synthase (ATP5A)Moderate
  • Oxidative stress / amyloid toxicityModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Limited human safety data: the side-effect profile is unknown, evidence is almost entirely from animal and preclinical studies.
  • Theoretical fatigue or energy-level fluctuation arising from its mitochondrial mechanism (not confirmed in humans).
  • Mild gastrointestinal discomfort (nausea, bloating) is plausible given the curcumin-related structure, but undocumented in humans.
  • Possible headache or mild dizziness, as with most CNS-active neurotrophic compounds (anecdotal, not clinical).
  • Unknown long-term safety: chronic toxicity, hepatic and renal effect data in humans are not available.
  • Purity and contamination risk from research-chemical market sources (unknown composition, no pharmaceutical-grade quality control).

Contraindications · 5

  • Pregnancy and breastfeeding: avoid, as no reproductive or developmental safety data exist.
  • Not an FDA-approved compound, only an investigational agent: human use without medical supervision is not recommended.
  • Given the curcumin-related structure, a theoretical antiplatelet, anticoagulant effect: caution advised alongside anticoagulant or antiplatelet therapy.
  • Unknown drug interactions: human effects on mitochondrial and CYP enzymes are not characterized, avoid in polypharmacy.
  • Avoid in hepatic or renal impairment: metabolism and excretion in humans are unknown.

Related Nootropics

Same therapeutic category

FAQ

FAQ

J-147 is a compound developed at a research institute (the Salk Institute) by chemically modifying curcumin, the active ingredient in turmeric, with the goal of making it act more effectively on brain cells. Research suggests it works on the cell's energy-producing centers (mitochondria) and boosts production of a protein needed for nerve cell growth and survival. For now it remains strictly a laboratory and animal-study research compound, with no data on human use.

Telegram

Have a question about J‑147?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC18H17F3N4O
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.